5 In 2013, the GHSG analyzed the different early-stage cHL classification schemes and found that age was not a significant factor, extranodal disease and ESR had borderline significance, while bulk mediastinal mass and number of node sites were prominent factors. 24 Furthermore, there was low specificity with high rates of false-positive results in all classification schemes (1-specificity of 53–55%).
← all excerpts
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.
1
—
—